Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. South Korea In-vitro Diagnostics Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Reagents, Software & Services)
5.2.2. By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others)
5.2.3. By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others)
5.2.4. By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Technology
5.3.3. By Application
5.3.4. By End User
5.3.5. Region
6. South Korea Immunoassay Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Instruments, Reagents, Software & Services)
6.2.2. By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others)
6.2.3. By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others)
6.2.4. By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others)
7. South Korea Hematology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Instruments, Reagents, Software & Services)
7.2.2. By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others)
7.2.3. By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others)
7.2.4. By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others)
8. South Korea Clinical Chemistry Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Instruments, Reagents, Software & Services)
8.2.2. By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others)
8.2.3. By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others)
8.2.4. By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others)
9. South Korea Molecular Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Instruments, Reagents, Software & Services)
9.2.2. By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others)
9.2.3. By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others)
9.2.4. By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others)
10. South Korea Microbiology Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Instruments, Reagents, Software & Services)
10.2.2. By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others)
10.2.3. By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others)
10.2.4. By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others)
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Merger & Acquisition
12.3. Product Launches
13. Policy & Regulatory Landscape
14. South Korea Economic Profile
15. South Korea In-vitro Diagnostics: SWOT Analysis
16. Competitive Landscape
16.1. Business Overview
16.2. Product Offerings
16.3. Recent Developments
16.4. Financials (As Reported)
16.5. Key Personnel
16.6. SWOT Analysis
16.6.1. Abbott Korea Ltd.
16.6.2. Becton Dickinson Korea Ltd.
16.6.3. Siemens Healthineers AG
16.6.4. Bio-Rad Laboratories Inc.
16.6.5. Danaher Corporation
16.6.6. FUJIFILM Business Innovation Korea Co., Ltd
16.6.7. Roche Korea Co Ltd.
17. Strategic Recommendations